5 Hypersensitivity
5 Hypersensitivity
Department of Pathology
College of Medicine &
Medical City
King Saud University
Reference
Kuby Immunology 8th Edition
Chapter 15
Objectives
• To know that hypersensitivity reactions are over and excessive
immune responses that can be harmful to body in four different
ways
Allergic reactions
- Cellular components:
Mast cells, basophiles & eosinophils
- Antigens:
Also known as allergens
(antigens with low molecular weight &
highly soluble)
Allergens
Some of the allergens involved in type I
hypersensitivity are: pollens, dust mite
allergens, animal dander, nuts, shellfish,
various drugs etc
Type I reactions occur in two phases
• Phase I :
- Sensitization phase
- Sensitization phase .
First contact
Type
Allergen Ienter with
Reaction allergens
occur
tissues in 2 phases:
, induce an
immune response . B – cells transform
to plasma cells & produce IgE.
“ Sensitized . “
Type I Hypersensitivity (Immediate)
Sensitization
Challenge
Primary and Secondary Mediators
Nose
Pharynx
Allergic rhinitis
Lungs
Esophagus Asthma
Food allergy
Stomach
Skin
Eczema
Urticaria
Allergic dermatitis
Allergy: Rhinitis, Eczema & Conjunctivitis
Normal nose
* Injected allergens:
Systemic inflammation
Anaphylactic shock
(life - threatening)
Anaphylactoid reactions:-
Are non - IgE mediated
may result from contrast media or
local anesthetics
Diagnosis of Allergy
Skin Prick test
• Features:-
- IgG (or IgM)
- Antigens: bound to
cell membranes
(Self antigens)
- Exogenous antigens
(microbial)
- Complement
activation
(Invariable)
Clinical examples:
Glomerulonephritis
(anti-glomerular
basement membrane)
Mis-matched blood
transfusion
Diagnosis
• Features
Antibody (IgG/ or IgM) + Antigen (soluble)
- Complement activation
• Features
• Cell mediated immune response
– Antigen dependent T cell (CD4 generally
and CD8 occasionally) activation via MHC
Class I or II
• Activated macrophages
• Delayed onset (2-4 days)
• Abnormal cellular response
– (Granuloma formation)
Mediators released by TDTH cells
Development of
DTH Response
Sensitization
phase:
1-2 week period
Effector phase:
24-72 hours
Effector cells
(activated macs)
act non-specifically
Pathophysiology of Contact dermatitis.
Type IV clinical examples:
Contact dermatitis
TB granuloma
(persistent antigen)
Diagnosis (Type IV)